Seeking adult men and women with multiple sclerosis for a study of an investigational drug that has not yet been tested in people.
Following a screening period of up to 4 weeks, participants in this study will get an infusion of the investigational drug and may need to stay in the clinic for up to 3 days. There will be 10 short follow-up visits.
What we're hoping for
We are studying how well an investigational drug for multiple sclerosis is tolerated at increasing doses.
ClinicalTrials.gov Identifier: Not Available